Mometasone Sandoz (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside nasal mucosal cells. The drug‑receptor complex moves into the cell nucleus and alters gene transcription, suppressing the production of inflammatory cytokines, chemokines, and adhesion molecules. This anti‑inflammatory action decreases swelling, mucus production, and immune cell infiltration, resulting in symptom relief.

The appropriate dose of Mometasone Sandoz is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Typically, one or two sprays per nostril once daily are used, but exact instructions should always follow the prescriber’s order and the product labeling.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss alternatives if concerns arise.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details—including any cold‑chain requirements—and necessary import documentation.

Mometasone furoate is a high‑potency intranasal glucocorticoid with a low systemic bioavailability, offering effective symptom control at once‑daily dosing. Compared with agents such as fluticasone or budesonide, mometasone often provides comparable or superior efficacy with a similar safety profile, though individual response may vary and choice depends on physician preference, patient tolerance, and formulary considerations.

The nasal spray should be stored at room temperature, preferably below 25 °C (77 °F). Keep the container in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use. Do not freeze the product, and discard any spray that has been used beyond the labeled expiration date.

Mometasone Sandoz is administered as a nasal spray. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and press down on the pump while breathing in gently through the nose. The recommended number of sprays per nostril is determined by the prescriber. After use, the nozzle should be cleaned with a clean tissue and replaced.

Although rare, serious adverse events can include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression when used at high doses or for prolonged periods. Patients should report persistent nosebleeds, visual changes, or signs of infection promptly. Regular monitoring by a healthcare professional helps mitigate these risks.

Mometasone Sandoz should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with untreated fungal, bacterial, or viral infections of the nasal passages, and in those who have experienced severe adverse reactions to other intranasal corticosteroids. Consultation with a healthcare provider is essential before initiating therapy.